Brainomix

United Kingdom
Saint Neots, England, United Kingdom, OX2 0JJ

Company profile

Brainomix company profile

Since launching as a spin-out from the University of Oxford in 2010, Brainomix has developed award-winning, AI-powered imaging biomarkers, assisting physicians across the world to make better life-saving decisions. Brainomix seminal product, e-Stroke is a collection of tools that use state-of-the-art AI algorithms to support doctors by providing real-time interpretation of brain scans to help guide treatment and transfer decisions for stroke patients, allowing more patients to get the right treatment, in the right place, at the right time.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
51-100 employees
Revenue range
$0-$1M
Founded
2010-01-01, Year

Headquarters

Postal code
OX2 0JJ
Country code
GB
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Late Stage Venture
Funding rounds
8
Total equity funding
$53.2M
Last funding
Series C / $18.2M / 2025-03-18
Last equity funding
Series C / $18.2M
Investors
9
Lead investors
5
Founders
2
Articles
139

Founders and investors

Founders

Andrew BarkerMichalis Papadakis

Lead investors

Boehringer Ingelheim Venture FundChimera PartnersEISMEAInnovate UKParkwalk Advisors

Investors

Boehringer Ingelheim Venture FundEISMEAInnovate UKParkwalk AdvisorsTencent